Breast Cancer Update

ResearchToPractice.com/BCU – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 43yo w/ER+/PR+/HER2+ breast cancer, paratracheal and cervical nodal metastases and a solitary liver lesion. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 61yo w/2.1-cm, ER+ IDC w/3 pos nodes treated with adjuvant TC > adjuvant tam for 5yr+ > AI. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 41yo w/strong family history of BC presented w/1.5-cm, poorly diff, trip-neg, clinically node-neg IDC & synchronous omental/liver metastases. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 35yo with a poorly diff 2-cm, ER-/PR-/HER2+ tumor & 3 pos nodes. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 48yo treated w/FEC doce for 3-cm, Grade II, trip-neg, node-pos IDC; developed biopsy-confirmed lung/liver mets +1yr. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 36yo, 17wks pregnant presents w/poorly diff 1- to 2-cm, ER+/PR+/HER2-, node-neg breast tumor. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – 32yo, 2 cancerous lymph nodes, susp lung/liver lesions 6y after adj chemo/trast & tam for 1.5-cm, ER+/PR+/HER2+ br tumor w/1 pos node. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/BCU/JournalClub – CME Information and Program PDF. Moderated by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/SABCS_2008 – Second Opinion: Proceedings and Interviews from a 2-Part CME Satellite Symposia Held at the 31st Annual San Antonio Breast Cancer Symposium. Case: 38-year-old premenopausal woman with a 2-cm, Grade III, ER/PR-positive, HER2-positive IDC and a 1.8-cm, biopsy-confirmed hepatic metastasis. Interviews conducted by Neil Love, MD. Produced by Research To Practice.